Begleiter A, Pugh L, Israels L G, Johnston J B
Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.
Cancer Res. 1988 Jul 15;48(14):3981-6.
The effects of irradiation were evaluated in L5178Y lymphoblasts treated with the adenosine deaminase inhibitor, 2'-deoxycoformycin, and deoxyadenosine. A synergistic antitumor effect was observed in resting cells between irradiation and 2'-deoxycoformycin/deoxyadenosine, with the dose required to reduce the surviving cell fraction to 0.1 being 25% lower than predicted for an additive effect. Synergy was enhanced with increasing deoxyadenosine concentration or with increasing radiation dose. When cells were treated with 2'-deoxycoformycin/deoxyadenosine for 1 h prior to irradiation, synergy was increased by prolonging postirradiation drug treatment. With 4-h postirradiation exposure to drug, varying the preirradiation incubation time did not affect synergy. In contrast, only a small enhancement of antitumor activity was observed in irradiated proliferating cells treated with 2'-deoxycoformycin/deoxyadenosine. Incubation of resting cells with 2'-deoxycoformycin/deoxyadenosine resulted in inhibition of the rate and extent of repair of radiation-induced DNA single strand breaks and an increase in dATP, but had no effect on NAD or ATP. With removal of drug, the dATP level fell rapidly and DNA repair resumed. Repair of DNA single strand breaks was more rapid in proliferating cells than in resting cells and was minimally affected by 2'-deoxycoformycin/deoxyadenosine, although the accumulation of dATP in these cells was 2-fold greater than in resting cells. The repair of DNA single strand breaks in chronic lymphocytic leukemia cells was as rapid as for proliferating L5178Y cells, but repair was significantly inhibited by 2'-deoxycoformycin/deoxyadenosine. These results suggest that 2'-deoxycoformycin/deoxyadenosine can function as a radiosensitizer, and this effect is associated with the cellular accumulation of dATP and inhibition of repair of DNA single strand breaks.
在用腺苷脱氨酶抑制剂2'-脱氧助间型霉素和脱氧腺苷处理的L5178Y成淋巴细胞中评估了辐射的效应。在静止细胞中观察到辐射与2'-脱氧助间型霉素/脱氧腺苷之间存在协同抗肿瘤效应,将存活细胞分数降低至0.1所需的剂量比相加效应预测值低25%。随着脱氧腺苷浓度增加或辐射剂量增加,协同作用增强。当细胞在辐射前用2'-脱氧助间型霉素/脱氧腺苷处理1小时时,延长辐射后药物处理可增强协同作用。辐射后药物暴露4小时,改变辐射前孵育时间不影响协同作用。相比之下,在用2'-脱氧助间型霉素/脱氧腺苷处理的辐射增殖细胞中仅观察到抗肿瘤活性有小幅增强。用2'-脱氧助间型霉素/脱氧腺苷孵育静止细胞导致辐射诱导的DNA单链断裂修复速率和程度受到抑制,dATP增加,但对NAD或ATP无影响。去除药物后 dATP 水平迅速下降,DNA 修复恢复。增殖细胞中DNA单链断裂的修复比静止细胞更快,并且受2'-脱氧助间型霉素 / 脱氧腺苷的影响最小,尽管这些细胞中dATP的积累比静止细胞多2倍。慢性淋巴细胞白血病细胞中DNA单链断裂的修复与增殖的L5178Y细胞一样快,但修复受到2'-脱氧助间型霉素/脱氧腺苷的显著抑制。这些结果表明,2'-脱氧助间型霉素/脱氧腺苷可作为放射增敏剂发挥作用,这种效应与dATP的细胞积累和DNA单链断裂修复的抑制有关。